<DOC>
	<DOCNO>NCT02004496</DOCNO>
	<brief_summary>Health care increasingly demand mobile application ( App ) , study rare , explore add value benefit patient physician . Patients different disease group physicians different specialty likely different demand . Research focus select group well understand individual demand . Our study intend identify added value mobile symptom track select subgroup patient . We design App breast cancer patient , receive ambulant chemotherapy breast center . The patient track regularly well-being adverse event ( AE ) smartphone- web-app share physician medical consultation . The data entry design meet patient need base previous usability test . The reporting AE well-being standardize accord definition CTCAE 4.0 ECOG-Index ensure reliability patient self-reporting . The primary outcome number report AE , influence subjective well-being acceptance context specific information . We include 150 participant study . The calculated power 91 % respectively 80 % 10 % improvement well-being 2.2 increase detect AEs . The result compare patient without App patient App without share information . - Trial medical device</brief_summary>
	<brief_title>Randomized Controlled Single-blind Trial Evaluate Mobile Tracking Symptoms Ambulatory Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion criterion : female 18 year old old German speak write informed consent begin intravenous chemotherapy breast care center diagnosis breast cancer personal smartphone ( device ) Exclusion criterion : patient meet inclusion criterion compliance could question , e.g . due psychiatric illness personal life .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>